4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0000950170-25-082472
Director acquired 21,130 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP Director | 2025-06-03 | Grant or award | +10,565 | 336,867 | I | ||
| BAKER BROS. ADVISORS LP Director | 2025-06-03 | Grant or award | +10,565 | 3,415,958 | I | ||
| Derivatives | |||||||
| BAKER BROS. ADVISORS LP Director | 2025-06-03 | Grant or award · Non-Qualified Stock Option (right to buy)uy) | +31,695 | 31,695 | I | ||
| BAKER BROS. ADVISORS LP Director | 2025-06-03 | Grant or award · Non- Qualified Stock Option (right to buy) | +31,695 | 31,695 | I | ||
Loading xslF345X05/ownership.xml…